NASDAQ:AMPH Amphastar Pharmaceuticals Q3 2025 Earnings Report $23.51 -0.12 (-0.51%) Closing price 04:00 PM EasternExtended Trading$23.51 0.00 (0.00%) As of 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast Amphastar Pharmaceuticals EPS ResultsActual EPSN/AConsensus EPS $0.83Beat/MissN/AOne Year Ago EPSN/AAmphastar Pharmaceuticals Revenue ResultsActual RevenueN/AExpected Revenue$186.90 millionBeat/MissN/AYoY Revenue GrowthN/AAmphastar Pharmaceuticals Announcement DetailsQuarterQ3 2025Date11/5/2025TimeBefore Market OpensConference Call DateWednesday, November 5, 2025Conference Call Time5:00PM ETConference Call ResourcesEarnings HistoryCompany Profile Amphastar Pharmaceuticals Earnings HeadlinesCritical Survey: Aspen Pharmacare (OTCMKTS:APNHY) versus Amphastar Pharmaceuticals (NASDAQ:AMPH)October 5, 2025 | americanbankingnews.comAfter Protracted Sell-Off, Amphastar Looks Like A Value PickSeptember 23, 2025 | seekingalpha.comOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.October 13 at 2:00 AM | Banyan Hill Publishing (Ad)Hazeltree Report: Large-Cap Tech Shorts Rise, Index Hedges Reappear; EMEA/APAC See Sharp Utilization SpikesSeptember 11, 2025 | finance.yahoo.comA Fresh Look at Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price MomentumSeptember 10, 2025 | finance.yahoo.comA Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The PackSeptember 5, 2025 | finance.yahoo.comSee More Amphastar Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Amphastar Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amphastar Pharmaceuticals and other key companies, straight to your email. Email Address About Amphastar PharmaceuticalsAmphastar Pharmaceuticals (NASDAQ:AMPH) is a specialty pharmaceutical company headquartered in Rancho Cucamonga, California. Founded in 2004, Amphastar focuses on the development, manufacturing and commercialization of injectable and inhalation products. The company’s manufacturing facilities in California produce both generic and proprietary formulations designed to address urgent and chronic medical conditions. Amphastar’s portfolio includes a range of injectable generics such as epinephrine, naloxone and lidocaine, serving hospital, emergency medical and retail pharmacy channels. The company also markets proprietary respiratory therapies, including over-the-counter inhaled products. Amphastar leverages its in-house drug delivery technologies to support both its own product lines and contract manufacturing services for third-party partners. In addition to marketed products, Amphastar maintains a pipeline of new drug candidates and device enhancements, including next-generation inhalation systems and branded formulations. The company’s research and development efforts are centered on improving patient access to essential medications while advancing delivery platforms that enhance convenience and dosing precision. Amphastar primarily serves the U.S. pharmaceutical market, with select international distribution partnerships. Leadership is anchored by Chief Executive Officer Enno Walther, who oversees strategic growth initiatives and manufacturing operations. The company is governed by a board of directors with experience in pharmaceutical development, regulatory affairs and commercial strategy.View Amphastar Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi Deal Upcoming Earnings America Movil (10/14/2025)BlackRock (10/14/2025)Citigroup (10/14/2025)The Goldman Sachs Group (10/14/2025)Johnson & Johnson (10/14/2025)JPMorgan Chase & Co. (10/14/2025)Wells Fargo & Company (10/14/2025)ASML (10/15/2025)Abbott Laboratories (10/15/2025)Bank of America (10/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
